Takeda Pharmaceutical (TAK) total liabilities

Total liabilities · fiscal 2026
¥8.08T

Takeda Pharmaceutical (TAK) had total liabilities of ¥8.08T at the end of fiscal 2026 (March 31, 2026). That is 10.5% higher than the ¥7.31T of fiscal 2025. Figures as of 18 Nov 2026, 18:27 UTC, from Yahoo Finance.

Key facts

Total liabilities, fiscal 2026
¥8.08T
Change on fiscal 2025
+10.5%
Highest on record
¥8.08Tfiscal 2026
Lowest on record
¥7.31Tfiscal 2025
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in JPY. Figures, not advice.

Takeda Pharmaceutical total liabilities, in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ¥8.08T in fiscal 2026 and the lowest ¥7.31T in fiscal 2025.

History · 4 fiscal years

Total liabilities by fiscal year

Takeda Pharmaceutical total liabilities, year by year

Takeda Pharmaceutical (TAK) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2026¥8.08T 10.5% up
2025¥7.31T 6.7% down
2024¥7.83T 3.0% up
2023¥7.60T—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Takeda Pharmaceutical and comparable companies
CompanyTotal liabilitiesFiscal year
Takeda Pharmaceutical TAK¥8.08T2026
Cencora COR$74.84B2025
Boston Scientific BSX$19.20B2025
Cardinal Health CAH$60.02B2026
argenx ARGX$1.36B2025
Edwards Lifesciences EW$3.36B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TAK

Takeda Pharmaceutical, figure by figure

Takeda Pharmaceutical (TAK) overview: price, valuation and scorecardAll health care companies by market value

Takeda Pharmaceutical total liabilities: questions and answers

How large are Takeda Pharmaceutical's total liabilities?

Takeda Pharmaceutical (TAK) had total liabilities of ¥8.08T at the end of fiscal 2026 (March 31, 2026). That is 10.5% higher than the ¥7.31T of fiscal 2025.

What are the highest and lowest total liabilities figures on record for Takeda Pharmaceutical?

Across the 4 fiscal years on record (2023–2026), the highest was ¥8.08T in fiscal 2026 and the lowest ¥7.31T in fiscal 2025.

How is Takeda Pharmaceutical's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Takeda Pharmaceutical it is on record here for 4 fiscal years, 2023 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Takeda Pharmaceutical (TAK) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/TAK/total-liabilities

Underlying data: Yahoo Finance.